Protein-based therapeutics are an attractive alternative to established therapeutic
approaches and represent one of the fastest growing families of drugs. While many of these …

Throughout the past decade, there has been a rapid growth in the development of
protein/peptide-based therapeutics. These therapeutics have found widespread applications …

Liposomes are well-established systems for drug delivery and biosensing applications. The
design of a liposomal carrier requires careful choice of lipid composition and formulation …

The membrane‐protein interface on lipid‐based nanoparticles influences their in vivo
behavior. Better understanding may evolve current drug delivery methods toward effective …

Lipid nanoparticles (LNPs) are versatile structures with tunable physicochemical properties
that are ideally suited as a platform for vaccine delivery and RNA therapeutics. A key barrier …

Listeriosis is one of the most serious foodborne diseases caused by the intracellular
bacterium Listeria monocytogenes. Its two major virulence factors, broad-range …

Diacylglycerols (DAGs) are bioactive lipids that are ubiquitously present at low
concentrations in cellular membranes. Upon the activation of lipid remodeling enzymes such …

Plasma lipid transport and metabolism are essential to ensure correct cellular function
throughout the body. Dynamically regulated in time and space, the well‐characterized …

Listeria monocytogenes is an intracellular food-borne pathogen that causes listeriosis, a
severe and potentially life-threatening disease. Listeria uses a number of virulence factors to …

The high physiology and low toxicity of therapeutic peptides and proteins have made them a
hot spot for drug development in recent years. However, their poor oral bioavailability and …